These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4068219)

  • 41. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Kimura H; Takeuchi H; Ishikawa H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
    Jpn J Antibiot; 1989 Jul; 42(7):1593-606. PubMed ID: 2562789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical effect of cefotiam on otorhinolaryngologic infections].
    Nakashima T; Makishima K; Toriya Y; Murata Y; Watanabe H; Kannae S
    Jpn J Antibiot; 1983 Oct; 36(10):2733-41. PubMed ID: 6325744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Some investigations on cefadroxil dry syrup (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Yamaguchi T
    Jpn J Antibiot; 1981 Feb; 34(2):171-9. PubMed ID: 7253197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical evaluation of cefprozil in children].
    Mochizuki Y; Kanazashi S; Hata D; Ohkubo H; Itoh S; Mayumi M; Mikawa H
    Jpn J Antibiot; 1992 Dec; 45(12):1622-34. PubMed ID: 1289580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical study of S 6472 in urinary tract infection].
    Takagi S; Arakawa S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Ishigami J; Umezu K; Yamanaka N; Sugimoto M
    Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative treatment trial of augmentin versus cefaclor for acute otitis media with effusion.
    Odio CM; Kusmiesz H; Shelton S; Nelson JD
    Pediatrics; 1985 May; 75(5):819-26. PubMed ID: 4039433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
    Sasaki I; Morihana T; Kaneko A; Michi K; Takahashi K; Fukuoka F; Satoh T; Yoshinari N; Ohne M; Hara H
    Jpn J Antibiot; 1990 Dec; 43(12):2035-68. PubMed ID: 2086820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefaclor: summary of clinical experience.
    Kammer RB; Short LJ
    Infection; 1979; 7 Suppl 6():631-5. PubMed ID: 551092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical studies of cefotiam in the field of otorhinolaryngology].
    Takeda K; Yoshida M; Ishida T
    Jpn J Antibiot; 1983 Oct; 36(10):2715-20. PubMed ID: 6325741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefaclor in the treatment of infections of the ears, nose, and throat.
    Federspil P; Bach R
    Postgrad Med J; 1979; 55 Suppl 4():53-5. PubMed ID: 548942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection].
    Arakawa S; Matsui T; Tanaka K; Ishigami J; Kamidono S; Ito N; Tanaka H; Hasunuma Y; Omae H; Shinozaki M
    Jpn J Antibiot; 1994 Feb; 47(2):195-209. PubMed ID: 8151912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S; Sugita R; Fujimaki Y; Deguchi K
    Jpn J Antibiot; 1983 Mar; 36(3):500-8. PubMed ID: 6553606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fundamental and clinical studies of cefaclor in oral surgery].
    Morihana K; Sakamoto H; Gotoh J; Konnai T; Uematsu M; Toyoura T; Sasaki J; Ohno K; Yoshida H; Hasegawa M
    Jpn J Antibiot; 1984 Jun; 37(6):1006-22. PubMed ID: 6387212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
    Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K
    Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
    Blumer JL; Mclinn SE; Deabate CA; Kafetzis DA; Perrotta RJ; Salgado O
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S115-20. PubMed ID: 7567311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of ceftazidime in the treatment of otorhinolaryngoiatric bacterial infections.
    Vellucci A; Marcucci L; Greco D; Schinaia N; Caterini A; Benedetti M
    Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):282-8. PubMed ID: 3298082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
    Iancu TC; Sinoff G
    Isr J Med Sci; 1983 Nov; 19(11):998-1000. PubMed ID: 6662693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of cefaclor.
    Derry JE
    Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome-oriented managed care comparing efficacies of cefaclor and amoxicillin in acute and recurrent acute otitis media.
    Perry BP; Zieno SA; Yonkers AJ; Moore GF
    Ear Nose Throat J; 1995 Dec; 74(12):840-4. PubMed ID: 8556984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.